New Duchenne muscular dystrophy drug approved
Dr. Krista Vandenborne and UF team played major role in success of newly approved Duchenne muscular dystrophy drug.
Dr. Krista Vandenborne and UF team played major role in success of newly approved Duchenne muscular dystrophy drug.
In The Conversation, Dr. Giridhar Kalamangalam tells the story of the game-changing medical test that measures brain electrical activity.
Dr. David Clark commented for United Press International story about new FAU study.
Dr. John Williamson featured for first GatorDocs podcast, produced by UF Continuing Education.
Learn about Dr. Maryam Rahman's impact in the OR and the lab.
Ceremony acknowledged Vaillancourt's exceptional contributions to the field, specifically within the realm of Parkinson's disease research.
Dr. Maryam Rahman has been awarded a $738K grant for preclinical testing of a novel cancer vaccine to treat malignant brain tumors.
Dr. David Vaillancourt was senior author on study in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
2024 College of Medicine award highlights outstanding research in clinical, data or artificial intelligence sciences.
Gene-editing study provides insight into mechanisms of how two proteins may accumulate in familial Parkinson’s disease.